Clinical Trial Protocol for Investigating Biological Characteristics of Different Syndromes in Heart Failure with Preserved Ejection Fraction (HFpEF) Based on Proteomics and Metabolomics Studies
Not Applicable
Recruiting
- Conditions
- Hearth failure
- Registration Number
- ITMCTR2024000120
- Lead Sponsor
- Xi Yuan Hospital, China Academy of Chinese Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Those who met the western medical diagnostic criteria for HFpEF; those who had a cardiac function (NYHA) classification standard of class II-IV; those who were 45-95 years old and of any gender; and those who gave consent from the patients or their families and signed the informed consent form.
Exclusion Criteria
Heart failure due to congenital heart disease, valvular heart disease, myocarditis, autoimmune disease, etc.; those with co-morbid malignant tumours; patients who refused to sign the informed consent form, and those with mental abnormality; women in pregnancy or breastfeeding; and those who have participated in other studies in the last 3 months.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method proteomics;LVEF;HbA1c;E/e';NT-pro BNP;metabolomics;EAT;
- Secondary Outcome Measures
Name Time Method